In its mission to simplify the complex payment and bidding process that
plagues the prescription drug benefits industry, today Truveris,
Inc. announced it closed a $10M oversubscribed Series B round of venture
funding, led by New
Leaf Venture Partners and joined by Tribeca
Venture Partners, New
Atlantic Ventures and First
Round Capital.
Since securing its Series A round of institutional capital a year ago,
Truveris launched TruGuard and TruBid, which drive efficiency,
transparency and cost containment for its 11 million participants in the
prescriptions claims process. Additionally, Truveris recruited a deep
bench of industry veterans that previously held executive roles at Medco
Health Solutions (NYSE: MHS), Empire Blue Cross Blue Shield, Oxford
Health Plans, CVS Caremark (NYSE: CVS) and PSS World Medical (NASDAQ:
PSSI). Truveris will use the new funds to expand the development and
operations teams to reach government entities, health insurance
companies, self-insured corporations and unions across the United States.
“Truveris offers a true innovation for payers of pharmacy benefits by
allowing real-time review of prescription claims billing, a process
traditionally plagued with inefficiencies,” said Philippe
Chambon, managing director, New Leaf Venture Partners. “Even minor
billing errors, when magnified over millions of claims, can result in
substantial costs to companies and ultimately the entire healthcare
system. Truveris real-time bill review technology allows firms to stop
overcharges while meeting CMS guidelines for Medicare-eligible pharmacy
benefits and thereby reducing potential liabilities for not meeting
compliance.”
Americans spend in excess of $307 billion a year on prescription drugs.
By serving as an intermediary among pharmacies, drug manufacturers and
employers, Pharmacy Benefit Managers (PBMs) can secure favorable pricing
for payers to minimize spending. Truveris, through its TruBid
product, helps these payers - insurance companies and self-insured
organizations - drive up to 12 percent savings annually by making their
request for proposals to PBMs through an automated, Web-based software
program, creating a reverse auction through the cloud. Setting up
benefits plans is an arduous task. This approach, which can be
implemented directly or through brokers, cuts the PBM selection time in
half, ensures standard contract terms, enforces drug pricing definitions
and establishes consistent benchmarks through an automated process. Once
health plan administrators have established a billing system with their
PBM, TruGuard will catch billing errors in real-time. TruGuard enables
payers with existing PBM contracts to verify and pay only for correctly
priced and adjudicated claims, prior to payment, rather than relying on
a manual, annual, less efficient retrospective audit.
“We are bringing cost effective technology solutions to an industry and
process that desperately needs them,” said Bryan
Birch, chairman, president and CEO, Truveris. “Based on reviewing
more than 100 million claims through our software-as-a-service platform,
we found that health plan administrators are being overcharged on every
bill. This new round of funding is a validation from the investor
community and industry professionals that this is an addressable issue.”
Bryan Birch remains the non-executive chairman of the board of Touchstone
Health Plans, a Medicare Advantage Heath Plan operating in 11 New
York State counties. Earlier this year, he was invited to present at the
UBS 22nd Annual 2012
Global Healthcare Services Conference along side companies including
Aetna (NYSE: AET), WellPoint (NYSE: WLP), Cigna (NYSE: CI), McKesson
(NYSE: MCK) and Walgreens (NYSE: WAG). Birch brings more than 20 years
of domain experience that includes senior executive roles at Medco
Health Solutions, Empire Blue Cross Blue Shield and Oxford Health Plans.
About Truveris
Founded in 2009, Truveris makes software to drive efficiency,
transparency and cost containment in the prescriptions claims process.
Truveris helps payers of pharmacy benefits negotiate agreements with
Prescription Benefit Managers (PBMs), validate claim payment accuracy,
ensure regulatory compliance, and manage pharmacy spend. Based in New
York City, Truveris is funded by First Round Capital, Tribeca Venture
Partners and New Atlantic Ventures. For more information, visit truveris.com.
